Literature DB >> 25873532

Using metformin in the presence of renal disease.

Tahseen A Chowdhury1, Roisin Wright2, M Magdi Yaqoob2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25873532     DOI： 10.1136/bmj.h1758

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Therapy: Risk of metformin use in patients with T2DM and advanced CKD.

Authors:  Guntram Schernthaner; Marie Helene Schernthaner-Reiter
Journal:  Nat Rev Endocrinol       Date:  2015-08-18       Impact factor: 43.330

Review 2.  Drug therapies in type 2 diabetes: an era of personalised medicine.

Authors:  Tahseen A Chowdhury; Paul Grant
Journal:  Clin Med (Lond)       Date:  2016-10       Impact factor: 2.659

3.  Berberine protects against metformin-associated lactic acidosis in induced diabetes mellitus.

Authors:  Suhail Ahmed Almani; Iqbal Ahmed Memon; Tariq Zaffar Shaikh; Haji Khan Khoharo; Ikramuddin Ujjan
Journal:  Iran J Basic Med Sci       Date:  2017-05       Impact factor: 2.699

4.  Lactic Acidosis in Diabetic Population: Is Metformin Implicated? Results of a Matched Case-Control Study Performed on the Type 2 Diabetes Population of Grenoble Hospital University.

Authors:  Marion Lepelley; Joris Giai; Nassima Yahiaoui; Sébastien Chanoine; Céline Villier
Journal:  J Diabetes Res       Date:  2016-02-29       Impact factor: 4.011
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.